Benzinga | Nov 2, 2021 04:56PM EDT

Halozyme Therapeutics Q3 EPS $1.48 Up From $0.25 YoY, Sales $115.83M Beat $101.94M Estimate

Halozyme Therapeutics (NASDAQ:HALO) reported quarterly earnings of $1.48 per share. This is a 492 percent increase over earnings of $0.25 per share from the same period last year. The company reported quarterly sales of $115.83 million which beat the analyst consensus estimate of $101.94 million by 13.63 percent. This is a 77.34 percent increase over sales of $65.32 million the same period last year.